What are the treatment options for a patient experiencing migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Treatment

For mild to moderate migraine attacks, start with NSAIDs (ibuprofen 400-800 mg, naproxen 500-825 mg, or aspirin 1000 mg) or the combination of aspirin-acetaminophen-caffeine; for moderate to severe attacks, use a triptan (sumatriptan 50-100 mg, rizatriptan, or zolmitriptan) combined with an NSAID for superior efficacy. 1, 2, 3

Stratified Treatment Algorithm

Mild to Moderate Migraine

  • First-line: NSAIDs are the initial treatment of choice 1, 3
    • Ibuprofen 400-800 mg 1
    • Naproxen sodium 500-825 mg 1
    • Aspirin 1000 mg 2
    • Aspirin-acetaminophen-caffeine combination (highly effective with NNT of 4 for pain relief at 2 hours) 2
  • Timing: Administer as early as possible during the attack to improve efficacy 4, 1
  • Alternative: Acetaminophen 1000 mg is less effective than NSAIDs but acceptable for patients intolerant of NSAIDs 2, 3

Moderate to Severe Migraine

  • First-line: Triptan + NSAID combination therapy 1, 2
    • Sumatriptan 50-100 mg PLUS naproxen sodium 500 mg provides superior efficacy compared to either agent alone, with 130 more patients per 1000 achieving sustained pain relief at 48 hours 1
    • Alternative triptans: rizatriptan, zolmitriptan, naratriptan 4, 1
  • Monotherapy option: Triptans alone if NSAIDs are contraindicated 1, 2
    • Sumatriptan 50-100 mg achieves headache response in 50-62% at 2 hours and 65-79% at 4 hours 5
    • If one triptan fails, try another as failure of one does not predict failure of others 2

Severe Migraine with Nausea/Vomiting

  • Use non-oral routes when significant nausea or vomiting is present 4, 1
  • IV combination therapy: Metoclopramide 10 mg IV + ketorolac 30 mg IV 1
    • Metoclopramide provides direct analgesic effects through central dopamine receptor antagonism, not just antiemetic effects 1
    • Ketorolac has rapid onset with 6-hour duration and minimal rebound headache risk 4, 1
  • Alternative: Prochlorperazine 10 mg IV effectively relieves headache pain 4, 1
  • Subcutaneous option: Sumatriptan 6 mg subcutaneous provides highest efficacy with 59% achieving complete pain relief by 2 hours and onset within 15 minutes 1
  • Intranasal option: Sumatriptan 5-20 mg nasal spray or other intranasal triptans 1

Second-Line and Rescue Treatments

When First-Line Treatments Fail

  • CGRP antagonists (gepants): Rimegepant, ubrogepant, or zavegepant 1, 3
    • NNT of 13 for pain freedom at 2 hours 2
  • Dihydroergotamine (DHE): Intranasal or IV formulation has good evidence for efficacy 4, 1
  • Lasmiditan (ditan): Reserved for patients who don't respond to all other treatments, but has significant adverse effects including driving restrictions 2, 3

Adjunctive Therapy for Associated Symptoms

  • Antiemetics treat nausea and provide synergistic analgesia 4, 1
    • Metoclopramide 10 mg (oral, IV, or IM) 4, 1
    • Prochlorperazine 10-25 mg (oral, IV, or rectal) 4, 1
  • Administer antiemetics 20-30 minutes before analgesics to improve gastric motility and medication absorption 1

Critical Medication Frequency Limits

Limit all acute migraine medications to no more than 2 days per week (or 10 days per month for triptans, 15 days per month for NSAIDs) to prevent medication-overuse headache. 1, 2, 3

  • Medication-overuse headache presents as daily headaches or marked increase in migraine frequency 4, 1
  • If patients require acute treatment more than twice weekly, initiate preventive therapy immediately 1, 2

Medications to Avoid

Never use opioids (hydromorphone, meperidine, oxycodone) or butalbital-containing compounds for routine migraine treatment. 4, 1, 2, 3

  • Opioids lead to dependency, rebound headaches, and eventual loss of efficacy 4, 1
  • Opioids should only be reserved for cases where all other medications cannot be used, sedation is not a concern, and abuse risk has been addressed 1
  • Butorphanol nasal spray has better evidence than other opioids if an opioid must be used 1

Contraindications and Safety Considerations

Triptan Contraindications

  • Absolute contraindications: Ischemic heart disease, coronary artery disease, Prinzmetal's variant angina, uncontrolled hypertension, history of stroke or TIA, Wolff-Parkinson-White syndrome 5
  • Cardiovascular risk: Triptans cause vasoconstriction and should not be used in patients with cardiovascular disease 3, 5
  • Serotonin syndrome risk: Use caution when combining with SSRIs, SNRIs, TCAs, or MAO inhibitors 5

NSAID Precautions

  • Ketorolac should be used with caution in renal impairment, history of GI bleeding, or heart disease 1
  • Monitor for medication-overuse headache with frequent NSAID use 4, 1

Pregnancy Considerations

  • Acetaminophen is the safest first-line option during pregnancy 3, 6
  • Sumatriptan may be an option for selected pregnant patients and is compatible with breastfeeding 6

When to Initiate Preventive Therapy

Start preventive therapy if patients have: 1, 2

  • Two or more attacks per month producing disability lasting 3+ days
  • Use of acute medication more than twice per week
  • Contraindication to or failure of acute treatments
  • Presence of uncommon migraine conditions (hemiplegic migraine, prolonged aura)

First-Line Preventive Options

  • Beta-blockers: Propranolol 80-240 mg/day or timolol 20-30 mg/day 1
  • Topiramate: Effective but requires discussion of teratogenic effects with patients of childbearing potential 2
  • OnabotulinumtoxinA 155 units: FDA-approved for chronic migraine (≥15 headache days per month) 2
  • CGRP monoclonal antibodies: Consider when oral preventives fail, with efficacy assessed after 3-6 months 1

Common Pitfalls to Avoid

  • Don't wait for severe pain to develop before treating—early administration improves efficacy 4, 1, 2
  • Don't use acetaminophen alone for migraine—it has limited efficacy as monotherapy but works well in combination with aspirin and caffeine 4, 2
  • Don't allow patients to increase acute medication frequency in response to treatment failure—this creates medication-overuse headache; instead transition to preventive therapy 1
  • Don't assume all triptans are the same—if one triptan fails, try another as response varies between agents 2
  • Don't use prednisone routinely for acute headache in urgent care—it has limited evidence and is more appropriate for status migrainosus 1

References

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Treatment Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Migraine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute Migraine Treatment.

Continuum (Minneapolis, Minn.), 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.